Education
About Us
Working with TipRanks
Follow Us
Healthcare Services Group (HCSG)
NASDAQ:HCSG
Top Page
Healthcare Services
(NASDAQ:HCSG)
Select Model
Select Model
Rating:73Outperform
Price Target:
$24.00
▲(25.26% Upside)
Action:ReiteratedDate:02/14/26
Score is driven by an improving financial profile (profitability and cash-flow rebound) and a strong balance sheet, reinforced by constructive 2026 guidance and shareholder-return actions from the earnings call. Technicals add support via a clear uptrend. Valuation tempers the score due to a relatively high P/E and no stated dividend yield.
Positive Factors
Conservative Balance Sheet
The company’s conservative, low‑debt balance sheet and substantial equity provide durable financial flexibility. Improved returns on equity in 2025 suggest profitability gains funded without leverage, enabling capital allocation, buybacks, or investment while limiting solvency risk.
Improving Cash Generation
Material improvement in operating cash flow in 2025 and adjusted cash flow aligning with earnings indicate stronger earnings quality and internal funding ability. Sustained cash generation supports reinvestment in operations, debt‑free growth initiatives, and consistent shareholder returns over the medium term.
Contract Upgrades & Scale
Systematic contract upgrades to service‑day billing and better pricing mechanics reduce DSO and make revenue/cash timing more predictable. The >$100M campus milestone also creates scale in a higher‑value vertical, supporting organic growth and targeted M&A execution.
Negative Factors
Compressed Margins
Margins remain materially below historical peaks despite recent net income gains. Limited operating leverage and thinner segment margins mean cost inflation, wage pressure, or contract mix shifts can quickly erode profitability, leaving margin recovery uncertain across cycles.
Cash Flow Volatility
Historical swings in operating and free cash flow, plus reliance on payroll accrual adjustments, show cash generation is inconsistent. That volatility complicates multi‑quarter capital planning and makes buybacks, reinvestment, or M&A timing riskier if cash flow reverts in weaker periods.
Growth Constrained by Talent
Management acknowledged organic growth is execution‑ and capacity‑constrained by a talent bottleneck. Difficulty scaling leadership and frontline managers limits the speed of new contract rollouts, margin improvement initiatives, and consistent quality delivery across sites over the medium term.
Healthcare Services (HCSG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.35B
Dividend YieldN/A
Average Volume (3M)804.27K
Price to Earnings (P/E)23.4
Beta (1Y)1.13
Revenue Growth6.26%
EPS Growth-19.33%
CountryUS
Employees35,300
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.44
Shares Outstanding70,267,586
10 Day Avg. Volume598,190
30 Day Avg. Volume804,273
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)2.71
Price to Sales (P/S)0.75
P/FCF Ratio9.95
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit4.98
Enterprise Value/Ebitda14.65
Forecast
1Y Price Target
$24.00Price Target Upside25.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.97
Revenue Forecast (FY)$1.93B
Healthcare Services Business Overview & Revenue Model
Company DescriptionHealthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the client's facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client's facility. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. As of December 31, 2021, the company provided its services to approximately 3,000 facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.
How the Company Makes MoneyHCSG generates revenue primarily through service contracts with healthcare facilities, which pay for the comprehensive management of food service operations, housekeeping, and laundry services. These contracts are typically established on a long-term basis, providing a steady stream of income. The company also benefits from economies of scale, as it serves a large number of clients across various states, allowing it to negotiate better terms with suppliers and optimize operational costs. Additionally, HCSG may engage in partnerships with healthcare providers to enhance service delivery and expand its market presence, further contributing to its revenue growth.
Healthcare Services Key Performance Indicators (KPIs)
Healthcare Services Earnings Call Summary
Earnings Call Date:Feb 11, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call emphasized multiple meaningful positives: revenue growth (6.6% YoY), segment margin expansion, a major campus revenue milestone (> $100M), strong adjusted cash generation, improved contract terms that enhanced collections and liquidity (cash and securities ~$204M, undrawn $300M revolver), and accelerated shareholder returns (completed buyback early and announced $75M plan). Lowlights were largely manageable or one-time in nature, including an $8.3M ERC-related tax benefit that will not recur, higher expected cash tax rate (~25% in 2026), quarter-to-quarter revenue sensitivity from service-day billing (~$10M Q4-to-Q1 impact), reliance on hiring management talent to scale growth, and some segment margin dispersion. Overall, positives materially outweigh the negatives, positioning the company for steady mid-single-digit growth while acknowledging near-term cadence and tax headwinds.Q4-2025 Updates
Positive Updates
Revenue Growth and Scale
Reported revenue of $466.7 million, representing a 6.6% year-over-year increase; management expects mid-single-digit revenue growth for full-year 2026 and Q1 2026 revenue in the $460–$465 million range.
Campus Division Milestone
Campus division surpassed $100 million in revenue, marking a significant growth milestone and providing a platform for further organic growth and targeted M&A over the next 12–18 months.
Segment Performance
Environmental Services revenue of $210.8 million with a segment margin of 12.6%; Dietary Services revenue of $255.9 million with a segment margin of 7.2% — both segments showed margin expansion in Q4 driven by operational execution.
Strong Margin and Cost Management
Cost of services was $394.6 million or 84.6% of revenue (management target ~86% in 2026); adjusted SG&A was $45.8 million or 9.8% of revenue (target range 9.5%–10.5%), reflecting disciplined expense control and operational execution.
Earnings and Adjusted Cash Flow
Net income of $31.2 million and diluted EPS of $0.44. Reported cash flow from operations was $17.4 million, and after adjusting for a $19.0 million decrease in payroll accrual, cash flow from operations was $36.4 million, demonstrating strong cash generation on an adjusted basis.
Balance Sheet and Liquidity Strength
Cash and marketable securities of $203.9 million at year-end and an undrawn $300 million revolving credit facility (utilization limited to LCs only), providing substantial liquidity and flexibility for growth and capital return.
Capital Return and Buyback Acceleration
Returned $61.6 million to shareholders in 2025 (including $19.6 million in Q4) and completed a $50 million buyback program five months early; announced a new plan to repurchase $75 million over the next 12 months and board authorization to repurchase up to 10 million shares.
Contract Upgrades and Improved Collections
Systematic contract upgrades (service-day billing, increased payment frequency, improved pricing mechanics) improved margin visibility and reduced days sales outstanding, contributing to stronger collections and more predictable cash flow.
Negative Updates
Tax Items and One-time ERC Benefit
Q4 included an $8.3 million ($0.12 per share) benefit tied to the tax treatment of certain ERC receipts; effective tax rate for the year was ~13% (Q4 reported as a 9.4% benefit) but management expects the 2026 effective tax rate to be approximately 25%, indicating a meaningful increase in cash tax going forward.
Service-Day Billing Creates Quarter-to-Quarter Variability
Contract shift to service-day-based billing introduced a pronounced Q4-to-Q1 dynamic: Q4 2025 had 92 service days vs Q1 2026 with 90 days — applied to Q4 revenue base this equals more than a $10 million headwind — creating near-term quarter cadence sensitivity.
Dependence on Hiring and Developing Management Candidates
Management emphasized that organic growth is execution- and capacity-constrained: the primary growth limiter is the ability to hire, develop and retain next-generation management candidates, which could cadence or constrain growth despite strong demand.
Cash Flow and Accrual Volatility
Reported cash from operations was modest at $17.4 million before a $19.0 million payroll accrual adjustment; variability in accrual timing and inconsistent bad debt expense could lead to quarter-to-quarter cash flow volatility.
Segment Margin Dispersion
Dietary Services margin of 7.2% materially lagged Environmental Services margin of 12.6%, highlighting uneven profitability across service lines and potential areas for margin improvement.
Uncertainty Around ERC Receipts
Some increase in cash and results during the year reflected ERC receipts; management noted they did not receive or recognize any ERC proceeds in Q4 and cautioned there is no certainty regarding future ERC receipts, meaning some prior benefits are non-recurring.
Company Guidance
Management guided to mid-single-digit revenue growth for fiscal 2026, with Q1 revenue expected in the $460–$465 million range, a step‑up in Q2 and sequential H2 vs H1 growth (noting a Q4→Q1 service‑day impact: 92 days in Q4 2025 vs 90 in Q1 2026, equating to >$10 million on the Q4 revenue base). Key operating targets are to manage cost of services around 86% and SG&A in a 9.5%–10.5% range (with a longer‑term goal of 8.5%–9.5%), and to carry an effective tax rate of approximately 25%; management reiterated that cash flow from operations should approximate net income excluding payroll‑accrual timing (Q4 cash flow from operations $17.4M, $36.4M adjusted for a $19M payroll accrual decrease; Q4 net income $31.2M and diluted EPS $0.44, which included an $8.3M/$0.12 per‑share ERC benefit). On liquidity and capital allocation they finished 2025 with $203.9M of cash and marketable securities, an undrawn $300M revolver (LCs only), completed a $50M repurchase program early (total repurchases of $61.6M in 2025, including $19.6M in Q4), received board authorization to buy up to 10M shares, and plan to repurchase $75M of common stock over the next 12 months.Healthcare Services Financial Statement Overview
Summary
Improving fundamentals led by a 2025 profitability rebound and stronger cash generation, supported by a very conservative, low-debt balance sheet. Offsetting this, margins remain relatively thin versus 2020–2021 levels and cash flow has been uneven across the last few years, raising durability/consistency risk.Income Statement
Revenue has re-accelerated, with 2025 up strongly versus 2024, and profitability improved meaningfully as net income rose sharply. That said, margins remain relatively thin and have generally compressed versus 2020–2021 levels, with EBIT and EBITDA margins lower in 2024–2025 than earlier in the period—suggesting operating leverage is limited and the business is still working back toward prior profitability.64
Positive
Balance Sheet
The balance sheet looks conservative: debt is very low relative to equity across the period, and equity remains substantial versus total assets. Returns on equity have improved into 2025, supporting the view that profitability is strengthening without relying on leverage; the main watch-out is that returns are still below the 2020 peak and assets/equity growth has been steady rather than dramatic.83
Very Positive
Cash Flow
Cash generation improved materially in 2025, with operating cash flow and free cash flow both strong and close to reported earnings, which supports earnings quality. Volatility is the key risk: operating and free cash flow were very weak in 2022 and modest in 2023–2024, and free cash flow declined in 2025 versus 2024—so consistency across cycles remains a question.71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.84B | 1.72B | 1.67B | 1.69B | 1.64B |
| Gross Profit | 239.41M | 228.09M | 214.75M | 193.31M | 230.57M |
| EBITDA | 65.32M | 73.96M | 75.26M | 62.86M | 81.56M |
| Net Income | 59.06M | 39.47M | 38.39M | 34.24M | 48.54M |
Balance Sheet | |||||
| Total Assets | 807.78M | 815.47M | 803.18M | 718.33M | 786.80M |
| Cash, Cash Equivalents and Short-Term Investments | 203.89M | 135.77M | 147.46M | 121.48M | 185.19M |
| Total Debt | 24.68M | 16.43M | 43.63M | 33.10M | 17.80M |
| Total Liabilities | 297.57M | 315.55M | 346.57M | 292.16M | 334.12M |
| Stockholders Equity | 510.21M | 499.93M | 456.62M | 426.17M | 452.68M |
Cash Flow | |||||
| Free Cash Flow | 139.15M | 24.47M | 38.09M | -13.38M | 31.42M |
| Operating Cash Flow | 144.97M | 30.80M | 43.50M | -8.17M | 37.11M |
| Investing Cash Flow | -11.00M | 6.05M | -3.29M | 2.58M | -22.99M |
| Financing Cash Flow | -63.33M | -31.05M | -12.15M | -38.93M | -82.65M |
Healthcare Services Technical Analysis
Negative
19.16
Price Trends
19.95
Negative
19.23
Negative
17.16
Positive
Market Momentum
-0.20
Positive
38.87
Neutral
29.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCSG, the sentiment is Negative. The current price of 19.16 is below the 20-day moving average (MA) of 20.64, below the 50-day MA of 19.95, and above the 200-day MA of 17.16, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 38.87 is Neutral, neither overbought nor oversold. The STOCH value of 29.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCSG.
Healthcare Services Risk Analysis
Healthcare Services disclosed 22 risk factors in its most recent earnings report. Healthcare Services reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Healthcare Services Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.35B | 23.43 | 11.83% | ― | 6.26% | -19.33% | |
72 Outperform | $1.11B | 28.23 | 10.87% | ― | 29.89% | 10.33% | |
65 Neutral | $1.24B | 9.15 | 18.28% | ― | 10.86% | 125.05% | |
62 Neutral | $1.12B | 78.68 | 3.12% | 2.25% | 17.50% | 154.28% | |
62 Neutral | $1.21B | 54.15 | 2.93% | ― | 68.17% | -85.42% | |
55 Neutral | $2.12B | -1.17 | -39.42% | ― | 4.58% | -61.50% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HCSG
Healthcare Services
19.16
8.74
83.88%
ACHC
Acadia Healthcare
22.96
-5.73
-19.97%
USPH
US Physical Therapy
74.33
3.23
4.55%
ASTH
Astrana Health
24.18
-6.71
-21.72%
PNTG
Pennant Group
32.06
8.66
37.01%
ARDT
Ardent Health Partners, Inc.
8.70
-4.44
-33.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.